Lifevantage Stock Crosses Below 200-Day Moving Average

Analysts Weigh In on Whether Investors Should Sell

Apr. 7, 2026 at 8:12am

Got story updates? Submit your updates here. ›

An extreme close-up of intricate, interlocking metal gears and machinery in shades of grey, bronze, and chrome, conveying the complex, powerful infrastructure of the banking industry.As Lifevantage stock falls below a key technical indicator, the company's financial machinery faces increased scrutiny from investors.Sandy Today

Shares of Lifevantage Corporation (NASDAQ:LFVN) have fallen below their 200-day moving average, raising questions about the company's stock performance. The nutritional supplements and skincare company's stock price closed at $4.18 on Monday, down from a 200-day average of $6.50.

Why it matters

Crossing below the 200-day moving average is often seen as a bearish signal, indicating a potential shift in the stock's long-term trend. This development could concern Lifevantage investors and prompt them to reevaluate their positions in the company.

The details

Lifevantage's stock has traded as low as $4.17 per share, well below its 200-day moving average. The company's shares last traded at $4.18, with a trading volume of 72,319. Analysts have provided mixed ratings on the stock, with one firm setting a $5.00 price target and another maintaining a 'hold' rating.

  • Lifevantage's stock price crossed below its 200-day moving average during trading on Monday.

The players

Lifevantage Corporation

A publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model.

Loop Capital

An investment firm that has set a $5.00 price target on Lifevantage shares.

Weiss Ratings

A research firm that has maintained a 'hold (c)' rating on Lifevantage stock.

Lake Street Capital

An investment firm that has reiterated a 'buy' rating on Lifevantage shares.

Got photos? Submit your photos here. ›

What’s next

Investors will be closely watching to see if Lifevantage's stock price can recover and regain its 200-day moving average in the coming days and weeks.

The takeaway

Lifevantage's stock crossing below its 200-day moving average is a concerning development that could prompt some investors to reevaluate their positions in the company. However, analysts remain divided on the stock's outlook, suggesting there is still uncertainty around the company's future performance.